Statistics and Info on Mysoline Abuse and Addiction in Southern California
In Southern California, and specifically in Los Angeles County, the misuse of prescription drugs like Mysoline continues to be a significant issue. In the fiscal year 2022-2023, sedatives were reported as the primary substance misused by 6.4 percent of individuals admitted for prescription drug-related problems.
Sedatives, including benzodiazepines, barbiturates like Mysoline, and other tranquilizers, still pose a significant challenge, with over 500 admissions linked to sedative misuse. Although Mysoline, a barbiturate often prescribed for epilepsy, represents a smaller fraction of sedative misuse, it plays a role in the wider prescription drug abuse crisis in the area. In Los Angeles, out of 1.48 million individuals affected by substance use disorder (SUD), only 34,297 are participating in publicly funded treatment programs, highlighting a significant disparity in available care. Local organizations, such as the Epilepsy Foundation Los Angeles, offer essential resources and support to those dealing with conditions requiring Mysoline while advocating for improved access to treatment and increased awareness of the issues surrounding sedative use and addiction.